PCPC Focused On Championing Risk-Based, Proportionate Policies Around The Globe In 2022

The Personal Care Products Council’s senior leadership team sat down with HBW Insight at the end of January to discuss the year ahead, including EU policy movement that could undermine long-standing chemical risk-assessment principles, disrupting international trade and proving infectious in other parts of the world.

The Personal Care Products Council is committed to fighting for risk-based, proportionate policies in the US and abroad as it faces another year of potentially radical change in the COVID era.

While a US trade association, PCPC’s remit is increasingly global as it advocates on behalf of 600 multinational cosmetics and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

Unanimous Support Across House Energy And Commerce To Reauthorize FDA’s OMUFA Program

 

Committee voted 51-0 to approve five-year authorization of FDA program user fee program needed to support regulatory pathway for large majority of nonprescription drugs available in the US with amendment to expand stakeholder engagement with FDA.

US Tariff Exemption For Indonesian Materials Not Produced Domestically A Boon For Fragrance – FCA

 

The Fragrance Creators Association President & CEO Farah Ahmed commends the Trump Administration for exempting from tariffs Indonesian goods not naturally available or produced in the US, which recognizes the “essential” role of fragrance and essential oils.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By 

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

Senate Appropriators Give US FDA More Non-User Fee Funds Than House

 

FDA would receive more funding for fiscal year 2026 in the Senate appropriations bill than its House counterpart, including $10m for unannounced foreign inspections.

More from Beauty

Senate Appropriators Give US FDA More Non-User Fee Funds Than House

 

FDA would receive more funding for fiscal year 2026 in the Senate appropriations bill than its House counterpart, including $10m for unannounced foreign inspections.

Oral Care Marketer’s Claims Not Supported By Weight-of-Evidence, Holistic Approach – NARB

 

Essor Group, Inc., marketer of Boka toothpastes and mouthwash, failed to convince the National Advertising Review Board that a weight-of-the-evidence or holistic approach could support claims its products could ‘remineralize’ teeth.